Pharmaceutical Preparations Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Pharmaceutical Preparations
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
100 results. Finviz
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company Name

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2023-01-25
BMRNBiomarin Pharmaceutical IncAjer Jeffrey RobertEVP, Chief Commercial OfficerS - Sale+OE$115.70-49,00041,088-54%-$5,669,134
DM
2023-01-26
PLRXPliant Therapeutics, Inc.Coulie BernardPres, CEOS - Sale+OE$35.32-55,000649,429-8%-$1,942,336
M
2023-01-25
GLYCGlycomimetics IncSandell Scott D10%S - Sale$3.14-3,652,0164,967,530-42%-$11,484,515
2023-01-26
MTCRMetacrine, Inc.York MichaelChief Business OfficerS - Sale$0.41-107,054103,499-51%-$44,331
2023-01-26
MTCRMetacrine, Inc.Klassen PrestonPres, CEOS - Sale$0.41-380,605541,905-41%-$157,266
2023-01-25
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerS - Sale$21.07-8,33667,815-11%-$175,640
2023-01-26
GBIOGeneration Bio Co.Paone AntoinetteCOOS - Sale$5.56-2,6950-100%-$14,984
DM
2023-01-25
VRTXVertex Pharmaceuticals Inc / MaLee YuchunDirS - Sale+OE$316.15-8,0001,875-81%-$2,529,174
2023-01-25
KZRKezar Life Sciences, Inc.Morningside Venture Investments Ltd10%S - Sale$6.85-50,0005,662,993-1%-$342,500
2023-01-25
VRTXVertex Pharmaceuticals Inc / MaKewalramani ReshmaCEO, PresS - Sale$315.05-10,00089,598-10%-$3,150,500
M
2023-01-25
MAIAMaia Biotechnology, Inc.Smith StanDirP - Purchase$4.24+236513,5640%+$1,001
2023-01-26
CMRXChimerix IncJakeman DavidPrincipal Accounting OfficerS - Sale$1.76-3,230136,752-2%-$5,686
D
2023-01-24
CTICCti Biopharma CorpCraig Adam RPres, CEOS - Sale+OE$6.00-85,31729,440-74%-$511,923
D
2023-01-24
CTICCti Biopharma CorpFong James KEVP, Chief Commercial OfficerS - Sale+OE$6.00-100,0003,565-97%-$600,000
DM
2023-01-24
UTHRUnited Therapeutics CorpRothblatt Martine AChairperson, CEOS - Sale+OE$261.88-16,000644,479-2%-$4,190,116
2023-01-24
PTCTPtc Therapeutics, Inc.Peltz Stuart WalterCEOS - Sale$47.45-28455,204-1%-$13,476
2023-01-24
PTCTPtc Therapeutics, Inc.Pauwels EricChief Business OfficerS - Sale$47.45-35965,912-1%-$17,035
2023-01-24
PTCTPtc Therapeutics, Inc.Hill Emily LuisaCFOS - Sale$47.45-22346,8630%-$10,582
2023-01-24
PTCTPtc Therapeutics, Inc.Almstead Neil GregoryChief Technical Ops OfficerS - Sale$47.45-443,287-1%-$2,088
M
2023-01-24
TVTXTravere Therapeutics, Inc.Calvin SandraSVP, Chief Accounting OfficerS - Sale$21.86-1,09734,836-3%-$23,976
2023-01-24
TVTXTravere Therapeutics, Inc.Rote William E.SVP, R, DS - Sale$21.50-2,06242,376-5%-$44,333
2023-01-24
TVTXTravere Therapeutics, Inc.Reed Elizabeth ESVP, GC, Corporate SecretaryS - Sale$21.50-2,06239,776-5%-$44,333
2023-01-24
TVTXTravere Therapeutics, Inc.Dube Eric MCEOS - Sale$21.50-6,442147,846-4%-$138,503
2023-01-24
TVTXTravere Therapeutics, Inc.Cline Christopher R.CFOS - Sale$21.90-85232,871-3%-$18,663
2023-01-24
TVTXTravere Therapeutics, Inc.Heerma PeterChief Commercial OfficerS - Sale$21.90-1,55063,598-2%-$33,952
2023-01-24
RAPTRapt Therapeutics, Inc.Ho WilliamChief Medical OfficerS - Sale$30.00-5,00030,072-14%-$150,000
2023-01-25
GALTGalectin Therapeutics IncEldred KaryDirP - Purchase$1.11+1,30050,640+3%+$1,443
2023-01-25
TOVXTheriva Biologics, Inc.Shallcross Steven ACEO, CFOP - Purchase$0.87+25,000160,000+19%+$21,825
DM
2023-01-23
PLRXPliant Therapeutics, Inc.Coulie BernardPres, CEOS - Sale+OE$33.12-60,000528,129-10%-$1,987,473
D
2023-01-23
PLRXPliant Therapeutics, Inc.Ouimette MikeGC, Corp. Sec'yS - Sale+OE$34.19-20,0005,947-77%-$683,878
2023-01-23
PLRXPliant Therapeutics, Inc.Lefebvre EricChief Medical OfficerS - Sale$34.48-67,50076,926-47%-$2,327,630
D
2023-01-23
PLRXPliant Therapeutics, Inc.Cummings Keith LamontCFOS - Sale+OE$35.00-30,00084,424-26%-$1,050,000
M
2023-01-23
KZRKezar Life Sciences, Inc.Morningside Venture Investments Ltd10%S - Sale$6.90-160,0005,712,993-3%-$1,103,200
2023-01-23
VAXXVaxxinity, Inc.Prime Movers Lab Fund I LP10%S - Sale$3.35-500,69216,754,036-3%-$1,678,019
DM
2023-01-23
TXMDTherapeuticsmd, Inc.Donegan Michael CPrin. Fin., Acctg. OfficerS - Sale+OE$5.34-1,3097,610-15%-$6,988
2023-01-23
ZYNEZynerba Pharmaceuticals, Inc.Sebree Terri BPresS - Sale$0.60-24,661513,204-5%-$14,742
2023-01-23
ZYNEZynerba Pharmaceuticals, Inc.Fickenscher James ECFOS - Sale$0.60-17,769324,736-5%-$10,622
2023-01-23
ZYNEZynerba Pharmaceuticals, Inc.Rosenberger BrianVP, Commercial, Business Dev.S - Sale$0.60-12,663214,848-6%-$7,570
2023-01-23
ZYNEZynerba Pharmaceuticals, Inc.Anido ArmandoCOB, Chief Exec. OfficerS - Sale$0.60-35,453866,127-4%-$21,194
2023-01-24
FOLDAmicus Therapeutics, Inc.Rosenberg EllenGCS - Sale$13.32-31,839347,345-8%-$424,006
2023-01-23
CTLTCatalent, Inc.Hopson RickyPres Clinical Dev Supply DivS - Sale$49.36-64316,452-4%-$31,738
2023-01-23
NGMNgm Biopharmaceuticals IncColumn Group L PDir, 10%P - Purchase$5.00+9,90021,536,5100%+$49,494
2023-01-23
NGMNgm Biopharmaceuticals IncColumn Group L PDir, 10%P - Purchase$5.00+9,90021,536,5100%+$49,494
2023-01-23
NGMNgm Biopharmaceuticals IncColumn Group L PDir, 10%P - Purchase$5.00+9,90021,536,5100%+$49,494
2023-01-23
NGMNgm Biopharmaceuticals IncGoeddel David VDir, 10%P - Purchase$5.00+9,90021,797,5100%+$49,494
2023-01-23
APLSApellis Pharmaceuticals, Inc.Lewis KarenChief People OfficerS - Sale$51.58-2,95537,709-7%-$152,419
2023-01-23
APLSApellis Pharmaceuticals, Inc.Eisele JeffreyChief Development OfficerS - Sale$51.58-4,47947,718-9%-$231,027
DM
2023-01-23
VRTXVertex Pharmaceuticals Inc / MaLee YuchunDirS - Sale+OE$312.46-6,1291,875-77%-$1,915,044
2023-01-20
BTAIBioxcel Therapeutics, Inc.Yocca FrankChief Scientific OfficerS - Sale$30.00-50,0008,397-86%-$1,500,000
D
2023-01-20
BTAIBioxcel Therapeutics, Inc.O'Neill VincentChief Medical OfficerS - Sale+OE$30.00-29,7130-100%-$891,390
D
2023-01-23
VTYXVentyx Biosciences, Inc.White William RichardDirS - Sale+OE$35.10-33,3530-100%-$1,170,592
2023-01-24
DCPHDeciphera Pharmaceuticals, Inc.Brightstar Associates LLC10%P - Purchase$18.00+1,666,66619,718,014+9%+$29,999,988
2023-01-23
DAWNDay One Biopharmaceuticals, Inc.Bender JeremyCEOS - Sale$22.00-12,5001,744,634-1%-$274,988
2023-01-20
FULCFulcrum Therapeutics, Inc.Ra Capital Management, L.P.10%P - Purchase$13.00+1,923,07611,609,704+20%+$24,999,988
DM
2023-01-20
UTHRUnited Therapeutics CorpRothblatt Martine AChairperson, CEOS - Sale+OE$259.79-16,000644,479-2%-$4,156,674
2023-01-20
GLSIGreenwich Lifesciences, Inc.Patel SnehalCEO, CFO, 10%P - Purchase$17.37+1,5002,732,8860%+$26,055
M
2023-01-19
ZYMEZymeworks Inc.Ecor1 Capital, LLC10%P - Purchase$9.70+307,5009,887,473+3%+$2,982,733
2023-01-20
DAWNDay One Biopharmaceuticals, Inc.York Charles N IICOO, CFO, SecretaryS - Sale$22.75-10,000268,810-4%-$227,523
2023-01-20
RVNCRevance Therapeutics, Inc.Schilke TobinCFOS - Sale$31.00-1,00057,877-2%-$31,000
D
2023-01-23
EVLOEvelo Biosciences, Inc.Carriere Stephen JPrincipal Accounting OfficerS - Sale+OE$1.06-151203-43%-$160
2023-01-23
ALBOAlbireo Pharma, Inc.Stephenson PamelaChief Commercial OfficerS - Sale$43.80-10242,7550%-$4,468
2023-01-23
ALBOAlbireo Pharma, Inc.Graham MichelleCHROS - Sale$43.80-10224,4930%-$4,468
2023-01-23
ALBOAlbireo Pharma, Inc.Mattsson JanChief Scientific OfficerS - Sale$43.80-19754,4740%-$8,629
2023-01-23
ALBOAlbireo Pharma, Inc.Harford Simon N.R.CFO, TreasurerS - Sale$43.80-10232,6890%-$4,468
2023-01-23
ALBOAlbireo Pharma, Inc.Duncan JasonGC, GCS - Sale$43.80-22814,146-2%-$9,986
2023-01-23
ALBOAlbireo Pharma, Inc.Cooper Ronald Harold WilfredPres, CEOS - Sale$43.80-1,05757,444-2%-$46,297
2023-01-23
CNTXContext Therapeutics Inc.Lehr Martin A.CEOP - Purchase$0.72+6,839956,395+1%+$4,901
2023-01-23
ALBOAlbireo Pharma, Inc.Carter Martha J.Chief Regulatory OfficerS - Sale$43.80-12014,506-1%-$5,256
M
2023-01-19
NGMNgm Biopharmaceuticals IncColumn Group L PDir, 10%P - Purchase$5.00+38,13921,526,6100%+$190,603
M
2023-01-19
NGMNgm Biopharmaceuticals IncColumn Group L PDir, 10%P - Purchase$5.00+38,13921,526,6100%+$190,603
2023-01-19
MGNXMacrogenics IncBiotech Target N V10%P - Purchase$5.30+150,0009,079,963+2%+$794,925
M
2023-01-19
NGMNgm Biopharmaceuticals IncColumn Group L PDir, 10%P - Purchase$5.00+38,13921,526,6100%+$190,603
M
2023-01-19
NGMNgm Biopharmaceuticals IncGoeddel David VDir, 10%P - Purchase$5.00+38,13921,787,6100%+$190,603
D
2023-01-18
DYNDyne Therapeutics, Inc.McNeill JonathanSee RemarksS - Sale+OE$14.03-10,00067,600-13%-$140,300
2023-01-20
TOVXTheriva Biologics, Inc.Shallcross Steven ACEO, CFOP - Purchase$0.75+25,000135,000+23%+$18,705
D
2023-01-18
PRTAProthena Corp Public Ltd CoNguyen TranChief Strategy Officer, CFOS - Sale+OE$55.53-10,0003,200-76%-$555,306
D
2023-01-18
PRVBProvention Bio, Inc.Palmer AshleighDir, CEOS - Sale+OE$10.27-24,1652,570,050-1%-$248,063
D
2023-01-18
PRVBProvention Bio, Inc.Leon FranciscoChief Scientific OfficerS - Sale+OE$10.27-24,0152,573,000-1%-$246,584
D
2023-01-20
PHATPhathom Pharmaceuticals, Inc.Curran TerriePres, Chief ExecS - Sale+OE$8.20-5,821179,043-3%-$47,729
2023-01-19
RAPTRapt Therapeutics, Inc.Ho WilliamChief Medical OfficerS - Sale$25.56-5,00035,072-12%-$127,800
D
2023-01-18
SUPNSupernus Pharmaceuticals, Inc.Khattar Jack A.Pres, CEOS - Sale+OE$40.40-4,9361,842,0170%-$199,394
2023-01-18
MYOVMyovant Sciences Ltd.Lang MatthewGC, Corp. Secy.S - Sale$26.89-1,272354,3030%-$34,204
2023-01-18
MYOVMyovant Sciences Ltd.Merendino LaurenChief Commercial OfficerS - Sale$26.89-2,008169,538-1%-$53,995
2023-01-18
MYOVMyovant Sciences Ltd.Marek David CPrincipal Exec OfficerS - Sale$26.89-8,037417,599-2%-$216,115
2020-04-13
KROSKeros Therapeutics, Inc.Knowles JuliusDirP - Purchase$20.98+1,191575,4920%+$24,987
2023-01-20
CLSDClearside Biomedical, Inc.Ciulla ThomasChief Medical OfficerS - Sale$1.47-13,700291,890-4%-$20,139
2023-01-18
MYOVMyovant Sciences Ltd.Arjona Ferreira Juan CamiloChief Medical OfficerS - Sale$26.89-1,109246,6840%-$29,821
2023-01-19
CLSDClearside Biomedical, Inc.Lasezkay George MCEOS - Sale$1.46-20,030484,577-4%-$29,244
DM
2023-01-18
UTHRUnited Therapeutics CorpRothblatt Martine AChairperson, CEOS - Sale+OE$259.83-16,000644,479-2%-$4,157,221
2023-01-19
CLSDClearside Biomedical, Inc.Deignan Charles A.CFOS - Sale$1.50-14,030363,472-4%-$21,045
2023-01-18
PRVBProvention Bio, Inc.Sessa Capital (Master), L.P.10%S - Sale$9.40-3,000,00011,879,023-20%-$28,200,000
2023-01-19
ALBOAlbireo Pharma, Inc.Carter Martha J.Chief Regulatory OfficerS - Sale$43.90-93814,626-6%-$41,182
2023-01-19
ALBOAlbireo Pharma, Inc.Duncan JasonGC, GCS - Sale$43.90-93814,374-6%-$41,182
2023-01-19
ALBOAlbireo Pharma, Inc.Stephenson PamelaChief Commercial OfficerS - Sale$43.90-1,77442,857-4%-$77,886
2023-01-19
ALBOAlbireo Pharma, Inc.Mattsson JanChief Scientific OfficerS - Sale$43.80-3,08854,671-5%-$135,254
2023-01-19
ALBOAlbireo Pharma, Inc.Graham MichelleCHROS - Sale$43.90-1,77424,595-7%-$77,886
2023-01-19
ALBOAlbireo Pharma, Inc.Harford Simon N.R.CFO, TreasurerS - Sale$43.80-1,77632,791-5%-$77,789
D
2023-01-18
QUREUniqure N.V.Soteropoulos PaulaDirS - Sale+OE$22.59-6,00016,382-27%-$135,540
2023-01-18
MRTXMirati Therapeutics, Inc.Cherrington Julie MDirS - Sale$44.66-2,5460-100%-$113,704
D
2023-01-17
RXDXPrometheus Biosciences, Inc.Marshall Keith WCFOS - Sale+OE$119.00-5,0009,811-34%-$595,000

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top